Entrada Therapeutics Inc (TRDA) Insider Trading
- $891,442.45
- $2,903,841.93
- April 8, 2024
- Dipal Doshi
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 8, 2024 | Director | 2,600 | $13.57 | Buy | $35,282.00 | |
March 28, 2024 | Director | 1,512 | $13.75 | Buy | $20,790.00 | |
March 25, 2024 | Director | 3,180 | $13.36 | Buy | $42,484.80 | |
March 21, 2024 | Director | 704 | $13.24 | Buy | $9,320.96 | |
March 19, 2024 | Director | 900 | $12.66 | Buy | $11,394.00 | |
Feb. 15, 2024 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Jan. 16, 2024 | CEO | 1,000 | $15.99 | Sell | $15,990.00 | |
Dec. 26, 2023 | CFO | 94 | $16.67 | Sell | $1,566.98 | |
Dec. 22, 2023 | CFO | 10,206 | $15.69 | Sell | $160,132.14 | |
Dec. 20, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Nov. 13, 2023 | CEO | 1,000 | $16.23 | Sell | $16,230.00 | |
Oct. 17, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Sept. 13, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Sept. 6, 2023 | CFO | 950 | $13.48 | Sell | $12,806.00 | |
Sept. 6, 2023 | COO | 972 | $13.47 | Sell | $13,092.84 | |
Sept. 6, 2023 | Insider | 892 | $13.48 | Sell | $12,024.16 | |
Aug. 14, 2023 | CEO | 1,000 | $15.67 | Sell | $15,670.00 | |
Aug. 4, 2023 | Insider | 6,898 | $14.14 | Sell | $97,537.72 | |
Aug. 2, 2023 | Insider | 10,348 | $15.19 | Sell | $157,186.12 | |
July 11, 2023 | CFO | 3,884 | $18.00 | Sell | $69,912.00 | |
July 10, 2023 | Insider | 3,026 | $18.00 | Sell | $54,468.00 | |
July 10, 2023 | COO | 3,200 | $18.00 | Sell | $57,600.00 | |
June 22, 2023 | COO | 7,097 | $16.02 | Sell | $113,693.94 | |
June 21, 2023 | CFO | 17,500 | $15.01 | Sell | $262,675.00 | |
June 20, 2023 | COO | 8,885 | $14.94 | Sell | $132,741.90 | |
April 27, 2023 | CEO | 2,000 | $13.71 | Sell | $27,420.00 | |
April 17, 2023 | CEO | 2,092 | $18.01 | Sell | $37,676.92 | |
April 17, 2023 | Insider | 3,961 | $18.00 | Sell | $71,298.00 | |
March 27, 2023 | CEO | 2,000 | $14.72 | Sell | $29,440.00 | |
Jan. 27, 2023 | CEO | 2,000 | $12.00 | Sell | $24,000.00 | |
Jan. 9, 2023 | CEO | 2,410 | $15.02 | Sell | $36,198.20 | |
Dec. 29, 2022 | CEO | 400 | $15.01 | Sell | $6,004.00 | |
Dec. 27, 2022 | CEO | 9,669 | $15.02 | Sell | $145,228.38 | |
Dec. 8, 2022 | CFO | 4,550 | $18.95 | Sell | $86,222.50 | |
Dec. 5, 2022 | CFO | 200 | $18.05 | Sell | $3,610.00 | |
Dec. 2, 2022 | CFO | 2,910 | $18.20 | Sell | $52,962.00 | |
Nov. 28, 2022 | CEO | 2,000 | $13.91 | Sell | $27,820.00 | |
Oct. 31, 2022 | COO | 2,100 | $24.05 | Sell | $50,505.00 | |
Oct. 27, 2022 | CEO | 2,000 | $21.66 | Sell | $43,320.00 | |
Oct. 25, 2022 | Insider | 8,040 | $20.88 | Sell | $167,875.20 | |
Oct. 24, 2022 | COO | 2,404 | $19.30 | Sell | $46,397.20 | |
Oct. 24, 2022 | CEO | 2,342 | $19.30 | Sell | $45,200.60 | |
Oct. 20, 2022 | CEO | 811 | $18.01 | Sell | $14,606.11 | |
Oct. 20, 2022 | COO | 905 | $18.07 | Sell | $16,353.35 | |
Sept. 28, 2022 | CEO | 3,085 | $15.23 | Sell | $46,984.55 | |
Sept. 28, 2022 | Insider | 3,122 | $15.25 | Sell | $47,610.50 | |
Sept. 26, 2022 | Insider | 3,068 | $15.33 | Sell | $47,032.44 | |
Sept. 26, 2022 | CEO | 3,083 | $15.32 | Sell | $47,231.56 | |
Sept. 26, 2022 | COO | 1,544 | $15.45 | Sell | $23,854.80 | |
Sept. 23, 2022 | CEO | 1,023 | $15.07 | Sell | $15,416.61 |
Insiders are both buying and selling Entrada Therapeutics Inc stock.
The insider traders at Entrada Therapeutics Inc are: Dipal Doshi, Nathan J Dowden, Kory James Wentworth, Nerissa Kreher, Bros. Advisors Lp Baker, Peter S Kim, Natarajan Sethuraman, and John F Crowley
The most active insider trader at Entrada Therapeutics Inc is Dipal Doshi with 28 trades.
Dipal Doshi has sold the most Entrada Therapeutics Inc stock with a total value of $835,721.49.
Bros. Advisors Lp Baker has bought the most Entrada Therapeutics Inc stock with a total value of $969,149.33.
The most recent insider trade for Entrada Therapeutics Inc was on April 8, 2024.
The single biggest insider buy for Entrada Therapeutics Inc was from Bros. Advisors Lp Baker with a total value of $245,528.64 on June 6, 2022.
The single biggest insider sell for Entrada Therapeutics Inc was from Kory James Wentworth with a total value of $262,675.00 on June 21, 2023.